Emergency treatment of acute psychosis

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 1, 1998, Pages 57-61

  Hillard, James Randolph ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOBARBITAL; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CLOZAPINE; DROPERIDOL; FLUPHENAZINE; HALOPERIDOL; LORAZEPAM; LOXAPINE; LOXAPINE SUCCINATE; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; TIOTIXENE; TRIFLUOPERAZINE; VALPROATE SEMISODIUM;

ACUTE PSYCHOSIS; DECISION THEORY; EMERGENCY TREATMENT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MANIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TRANQUILIZING ACTIVITY;

EID: 0031933476     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Hillard JR. The past and future of psychiatric emergency services in the US. Hosp Community Psychiatry 1994;45:541-543
2. Quitkin F, Rifkin A, Klein DF. Very high dosage vs standard dosage fluphenazine in schizophrenia. Arch Gen Psychiatry 1987;39:473-481
3. Donlon PT, Hopkin J, Tupin JP. Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol. Am J Psychiatry 1979;136:273-278
4. Raleigh FR. Reducing unnecessary antiparkinsonian medication in anti-psychotic therapy. J Am Pharmacol Assoc 1977;17:101-106
5. Lerner Y, Lwow E, Levitin A, et al. Acute high dose haloperidol treatment of psychosis. Am J Psychiatry 1979;136:1061-1064
6. Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in pharmacological treatment of psychoses. Arch Gen Psychiatry 1988;45:79-91
7. Tardiff K. Psychiatric Uses of Seclusion and Restraint. Washington, DC: American Psychiatric Press; 1984
8. Hillard JR. Manual of Clinical Emergency Psychiatry. Washington, DC: American Psychiatric Press; 1990:40
9. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989;146:717-725
10. Gardiner DL, Cowdry RW. Alprazolam-induced dyscontrol in borderline personality. Am J Psychiatry 1985;142:98-100
11. Dietch JT, Jennings RK. Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psychiatry 1988;49:184-188
12. Dubin WR, Waxman HM, Weiss KJ, et al. Rapid tranquilization: the efficacy of oral concentrate. J Clin Psychiatry 1985;46:475-478
13. Menza MA, Murray GB, Holmes VF, et al. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987;48: 278-280
14. Adams F. Neuropsychiatrie evaluation and treatment of delirium in the critically ill cancer patient. Cancer Bulletin 1984;36:156-160
15. Hunt N, Stern TA. The association between intravenous haloperidol and Torsades de Pointes: three cases and a literature review. Psychosomatics 1995;36:541-549
16. Mendoza R, Djenderedjian AH, Adams J, et al. Midazolam in acute psychotic patients with hyperarousal. J Clin Psychiatry 1987;48:291-292
17. Resnick M, Burton BT. Droperidol vs haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry 1984;45:298-299
18. Safferman A, Lieberman JA, Kane JM, et al. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991;17:247-261
19. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835
20. Beasley CM, Tollefson GD, Tran PV, et al. Olanzapine vs placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996;14:111-123
21. Rifkin A, Doddi S, Kavajgi B, et al. Dosage of haloperidol for mania. Br J Psychiatry 1994;165:113-116
22. Dwight MM, Keck PE, Stanton SP, et al. Antidepressant activity and mania associated with risperidone in the treatment of schizoaffective disorder. Lancet 1994:344 (8921):554-555
23. Sajatoric M, DiGovanni SK, Bastani B, et al. Risperidone therapy in treatment refractory acute bipolar and schizoaffective disorder. Psychopharmacol Bull 1996;32:55-61
24. McElroy SL, Keck PE Jr, Stanton SP, et al. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-146
25. Pickar D. Prospects for pharmacotherapy of schizophrenia. Lancet 1995;354:557-562
26. Moore NA, Calligaro DO, Wong DT, et al. The pharmacology of olanzapine and other new antipsychotic agents. Current Opinion in Investigational Drugs 1993;2:281-293
27. Fabre L, Slotnick V, Jones V. ICI 204.636, a novel atypical antipsychotic: early indications for safety and efficacy in man. Abstracts of the 17th Congress of Collegium Internationale Neuro-Psychopharmacologicum (CINP), vol 2. 1990;Kyoto, Japan
28. Sanchez C, Arnt J, Dragsted N, et al. Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Development Research 1991;22:239-250.
29. 2 antagonist activities. Soc Neurosci (Abstr) 1993;19:Abstr 666.1